Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients.

OBJECTIVE This study investigated the effect of insulin glargine (LANTUS) versus NPH insulin on metabolic control and safety in Asian patients with Type 2 diabetes, inadequately controlled on oral hypoglycemic agents (OHAs). STUDY DESIGN AND METHODS In this open-label, randomized, parallel, multinational, 24-week, non-inferiority study, 443 patients… CONTINUE READING